Business Operations

LEADERSHIP IN SUSTAINABLE CHEMISTRY

Divi’s has established three manufacturing facilities, offering a total combined capacity of ~16,500 m³ across three cGMP-compliant units. Operations at Unit 3, Phase-I, Kakinada began in January 2025.
We produce 100s/1000s of tons of APIs annually, exporting to over 100 countries and consistently meeting global pharmaceutical needs.
Our scalable manufacturing approach aligns capacity expansion with demand visibility, helping maximise efficiency.
A diverse team of ~20,100 professionals across three countries supports our operations, guided by a leadership team with decades of experience in manufacturing, R&D, and business development.

With ~700 scientists across R&D labs and Process Development and Support Centers (PDSC), we focus on green chemistry, continuous process improvement, and lifecycle efficiency. Our capabilities in complex chemistry support sustainable manufacturing.
More than 2,000 professionals in QA/QC form the backbone of our Quality System, ensuring compliance with global regulatory standards through rigorous testing and validation in state-of- the-art analytical labs.
We maintain strict global quality standards, delivering uniform product quality and reliability across all markets. Our facilities are approved by leading regulatory authorities and are trusted by Big Pharma and multinational companies worldwide.
With several global partnerships spanning over 20 years, Divi’s provides secure environments for proprietary processes and ensures on-time supply, IP protection, and process integrity.

Research & Development

Divi’s R&D team is focused on developing commercially viable processes that remain cost-effective throughout the product lifecycle, while continuously driving process improvements.

Manufacturing Facilities

Divi’s operates three manufacturing facilities that are compliant with global regulatory standards and are capable of producing annual requirements ranging from 10s of kilograms to 1000s of tons.

Quality Systems

All units adhere to cGMP guidelines and have successfully undergone multiple inspections by global health authorities including the FDA, EU GMP, Health Canada, TGA, ANVISA, COFEPRIS, PMDA, and MFDS.